, researchers applied it to over 3,500 blood samples from a broad variety of clients, some of whom had already been identified with cancer.”Our previous work suggested that methylation-based assays exceed traditional DNA-sequencing techniques to identifying several forms of cancer in blood samples,” Geoffrey Oxnard, MD, lead author of the research, said in a statement. Of particular note is the truth that the test dramatically decreases incorrect positives, with just 0.6% of outcomes suggesting the existence of cancer where none actually existed.
, scientists used it to over 3,500 blood samples from a broad variety of patients, some of whom had actually currently been detected with cancer.”Our previous work suggested that methylation-based assays exceed traditional DNA-sequencing techniques to spotting several forms of cancer in blood samples,” Geoffrey Oxnard, MD, lead author of the research study, stated in a declaration. Of specific note is the reality that the test dramatically minimizes incorrect positives, with simply 0.6% of results suggesting the presence of cancer where none actually existed.
Be First to Comment